Vaccines Market
Vaccines Market Analysis by Technology (Conjugate Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Viral Vector Vaccines), Type (Monovalent Vaccines and Multivalent Vaccines) & Region - Forecast to 2022-2032
Market Insights on Vaccines covering sales outlook, demand forecast & up-to-date key trends
Vaccines Market Outlook 2022-2032
[332 Pages Report] During the assessment period, the worldwide Vaccines Market Growth is predicted to rise at a robust CAGR of 10% from US$ 42 Bn in 2021 to US$ 120 Bn by 2032.
"Increasing public awareness of vaccination and government support in R&D are driving the market growth."
The rising supply of items to meet patient needs will grow the vaccine market. Increasing unmet needs and the worldwide goal to eliminate endemic illnesses will spur vaccine development. Pharmaceutical corporations, government foundations, international organisations, and hospitals work together to develop affordable vaccinations and immunisation regimens.
The government is expected to actively monitor the vaccines market growth at low or no cost to individuals in the future years. Companies' increased R&D expenditure for new items will increase vaccine market demand, benefiting the market.
|
Attributes |
Details |
|
Vaccines Market CAGR (2022 – 2032) |
10% |
|
Vaccines Market (2032) |
US$ 120 Bn |
|
Vaccines Market Attraction |
Advanced technology and cost efficiency are increasing the vaccines market growth. |
What is the Impact of COVID-19 on the Vaccines Market?
The outbreak of Covid-19 brought ample opportunities for the vaccine manufacturing companies to develop vaccines for preventing coronavirus infections. Some of them succeeded in finding different types of Covid-19 vaccine to prevent the spread.
These companies experienced some negative impacts during this period also. For instance, the complete focus of healthcare resources of every country was diverted towards meeting the challenge of rising infection cases side-lining the services provided for patients of other diseases.
As vaccination programmes to prevent other diseases were not possible, vaccine booking dropped down significantly, severely hampering manufacturing companies' business.
Let us know your requirement to get
100% FREE customization
What are the Dynamics of the Vaccines Market?
"Huge capital investments and low purchasing power in emerging markets may impede market development."
With humans travelling at a much higher rate and covering much greater distances than in the past, living in densely inhabited places, and coming into closer touch with wild animals, the potential for new infectious illnesses to spread swiftly and trigger worldwide epidemics is a big concern.
The vaccines market will continue to propel because illnesses may evolve due to terrorists' purposeful introduction into human, animal, or plant populations. Around 40 infectious illnesses have been found since the 1970s, including SARS, MERS, Ebola, chikungunya, and Zika, which is caused by a novel coronavirus, SARS-CoV-2.
Experts have predicted that future pandemics and epidemics would be deadlier than COVID-19. The increasing incidence of these infectious illnesses will ensure that demand for vaccines adoption trends continues to increase in the future years.
Additionally, the introduction of new illnesses will result in increased R&D spending, a robust pipeline, and new vaccines market opportunities for broad population sectors.
What are the Roadblocks to Expansion for Vaccines Market Players?
Vaccines development is a costly endeavour. The development process takes 10–15 years (from in vitro research to commercialisation) and involves an expenditure of Billion dollars. Vaccines research has a poor success rate; firms face difficulty securing early financing and managing operating costs.
Vaccines have more excellent storage and distribution cost than any other pharmaceutical medication, as they require specific infrastructure and monitoring systems. Inadequate storage and distribution facilities might result in a deterioration of vaccine quality. As a result, the high expense of developing and storing is impeding the expansion of the vaccines market.
What are the Most Important Trends and Opportunities for Vaccines Market?
Due to their large patient populations and rising disposable incomes, emerging regions such as India, China, and Southeast Asia represent the exciting potential for the vaccines market business. This development potential has attracted the attention of prominent market participants who have invested in these economies.
Numerous organisations and institutions, such as GAVI, are actively promoting vaccines market usage in impoverished countries, for example, by distributing vaccines at a cheap cost. As a result, these nations have emerged as crucial growth hotspots in the vaccines industry.
Another trend in emerging economies is an increase in demand for affordable vaccines. Businesses are investing in and concentrating their efforts on developing inexpensive, low-cost vaccines to expand the reach of immunisation programmes in these economies.
Which are the Threats Faced by Players in the Vaccines Market?
This is a critical issue in the industry, particularly in impoverished places where awareness campaigns and efforts have failed to penetrate adequately or entirely. Vaccines may also be unavailable in some instances, such as distant places, due to a lack of adequate storage facilities and government backing.
Other obstacles, such as poor literacy rates, a lack of health education, and financial constraints, have also hampered vaccines market access.
Comparative View of Adjacent Vaccines Market
Vaccines Market :
|
Attributes |
Vaccines Market |
|
CAGR (2022 - 2032) |
10% |
|
Market Value (2026) |
US$ 67 Bn |
|
Growth Factor |
Increasing focus on immunization of the populace to underpin growth. |
|
Opportunity |
Investments from governments to support vaccine development. |
|
Key Trends |
Development of vaccines with low response time to get better exposure. |
Veterinary Vaccines Market :
|
Attributes |
Veterinary Vaccines Market |
|
CAGR (2022 - 2032) |
7% |
|
Market Value (2026) |
US$ 12 Bn |
|
Growth Factor |
Demand for animal-based plant product generates high adoption of veterinary vaccines. |
|
Opportunity |
Increasing initiatives taken by governments to improve animal health creates opportunity for market players. |
|
Key Trends |
Rising focus on technological innovations to offer opportunities. |
COVID-19 Vaccines Market :
|
Attributes |
COVID-19 Vaccines Market |
|
CAGR (2022 - 2032) |
-15% |
|
Market Value (2026) |
US$ 1.4 Bn |
|
Growth Factor |
Rising investments towards COVID-19 vaccine development to drive significant growth. |
|
Opportunity |
Increasing focus on improving the efficiency of COVID-19 vaccines. |
|
Key Trends |
Investment towards R&D activities to underpin opportunities. |
Vaccine technology has evolved rapidly in the last decade, profoundly influencing the vaccines market future trends. The introduction of genetic engineering has fuelled many advances in vaccine development programmes and vaccine market structure, resulting in new products and the development of several virus vaccines that use an attenuated form of the virus, augmenting the overall vaccine industry profits.
Most of the vaccines market key trends & opportunities have been primarily driven by the need to shorten response times towards emerging threats and make possible vaccines market access to rapid deployment. Several vaccine market companies have shifted their focus to this aspect to scale up their market share.
The steadily rising necessity to develop the best vaccine against challenging targets and improve delivery systems for maximum potency also drives the demand for vaccine innovation. A few of the technological innovations among the recent developments in the vaccines market are the evolution of synthetic vaccine candidates, vaccine response, structure-based antigen design, and genomic analysis of disease progression, which effectively enhances the global vaccine market size.
As a result, technological advancements are expected to drive the development of new and more effective vaccines for a variety of new indications as well as surge vaccine industry profits, thereby propelling the vaccines market growth.
The vaccines market value is likely to expand positively as investments in research and development increase against various diseases. Furthermore, potential product launches are expected to enlarge the vaccines market size during the forecast period.
Several potential vaccine candidates in the global vaccine market, for example, are in the pipelines of pharmaceutical companies such as Pfizer, Johnson & Johnson, and others, thereby making a wide array of vaccines market opportunities available.
Scientists have begun to use artificial intelligence to sort and analyse potential vaccine development approaches far more quickly than any human team could through informed trial-and-error. This is expected to shape the vaccine market trends to a considerable level.
AI has the potential to improve the speed at which potential candidates are evaluated as technology advances, and this most likely resolves the issue involved in the vaccine market in the world, such as sifting through thousands of potential compounds to gauge the viability of the same by scientists which are considered to be one of the crucial emerging trends in the vaccines market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich are the Key Segments in the Vaccines Market?
By 2020, the conjugate vaccines segment accounted for the largest share of the global vaccine market by technology type under increased government spending and investment by companies on its development. The other technologies, such as inactivated, live attenuated, and recombinant vaccines, are also gaining demand and are predicted to occupy a substantial market share during the forecast period.
What are the Different Disease Indications in the Vaccines Market?
Different types of vaccines are developed and categorized based on the diseases used. Though Influenza diseases are the most widespread across all regions, indications of pneumococcal diseases account for the largest segment against all other disease indications.
The Indication of other diseases such as combination vaccines meningococcal disease are also growing in number in the contemporary world and are expected to increase the total volume of supply for vaccines.
Which Segment of End users are the Significant Contributors to the Vaccine Market?
Vaccines are developed to be used in both children and adults. The paediatric vaccines segment contributed a significant share of the global vaccine market, while the vaccine segment for adults will increase after the Covid-19 pandemic all over the world.
What are the Different Methods of Administration in the Vaccine Market?
Among all the routes of administration by which the vaccine market is categorized, Intramuscular and subcutaneous routes are the most preferred method by all healthcare professionals globally.
Oral and other routes of administration are also getting popular in the aftermath of the Covid-19 pandemic to increase the supply of contactless vaccine administration.
Why is North America the Leading Vaccines Market?
As most of the key players are present in North America, it is the largest market in all categories and will continue to grow faster than any other region of the world.
Along with the medical uses, pet vaccination is also a growing industry in developed regions. Vaccines for various animals, particularly dog vaccines, are in greater demand in North America and adjacent areas.
Government spending for immunization programs in the Asia Pacific region and African countries has positioned these parts of the world as lucrative markets for vaccine manufacturers. Increased awareness among people about vaccines and the developing healthcare sector that provides vaccine certificates has also increased the demand for vaccines at the individual level.
Moreover, the higher investment of public money and new business start-ups in the research and development of new vaccines poses a severe challenge to previously established players in the global vaccine market, as reported by some vaccine journals. Also, due to the massive population in the countries of these regions, the vaccine market is the primary focus of all the major players.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
How Intense is the Competition in the Vaccines Market?
Major players that are leading the vaccine market by research, development, production and distribution are Merck & Co., Inc; Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson & Johnson (J&J), AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation.
GSK, Pfizer, Mark and Sanofi are the largest manufacturers of vaccines controlling about 90% of the vaccine supply by volume. Manufacturers in Asia also increase their production capacity and are categorized under mid-size manufacturers.
Recent Developments in the Vaccines Market:
- VAXELIS, a combination of diphtheria toxoids, tetanus toxoids, acellular pertussis, inactive poliovirus, Haemophilus b conjugate, and hepatitis B, was developed and launched in 2021 by Merck along with Sanofi Pasteur.
- To control shingles or herpes zoster in adults, GSK developed a Zoster vaccine recombinant by the name of Shingrix vaccine. It received the approval of the US Food and Drug Administration (FDA) in 2021 to be used in 18 above adults who are at risk of the disease due to immunodeficiency or immunosuppression.
- By August 2021, the vaccine for Covid-19 developed by Pfizer-BioNTech named COMIRNATY was ready. It was first approved for adults by the US FDA, and later in October 2021, it received the emergency use authorization (EUA) for children of 5 to 11 years of age.
Key Segments
By Technology:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
By Type:
- Monovalent Vaccines
- Multivalent Vaccines
By Route of Administration:
- Intramuscular & Subcutaneous Administration
- Oral Administration
- Other routes (Intranasal, Intradermal and Percutaneous)
By Disease Indication:
- Influenza
- Pneumococcal Diseases
- Combination Vaccines
- HPV
- Herpes Zoster
- Meningococcal Diseases
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- Covid-19
- Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)
By End User:
- Pediatric Vaccines
- Adult Vaccines
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Frequently Asked Questions
The vaccines market is expected to register a 10% CAGR during the projected period.
In 2021, the vaccines market registered a value of US$ 42 Bn.
The vaccines market growth is predicted to reach a valuation of US$ 120 Bn by 2032.
North America is a key vaccines market.
By 2026, the vaccines market is expected to cross a valuation of US$ 67 Bn.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Vaccines Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Vaccines Market By Country, US$ Mn
4.2. Vaccines Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Vaccines Market Growth
4.5.3. Vaccines Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Vaccines Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Vaccines Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Vaccines Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032
8.3.1. Conjugate Vaccines
8.3.2. Inactivated & Subunit Vaccines
8.3.3. Live Attenuated Vaccines
8.3.4. Recombinant Vaccines
8.3.5. Toxoid Vaccines
8.3.6. Viral Vector Vaccines
8.4. Market Attractiveness Analysis By Technology
9. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Type
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Type, 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Type, 2022-2032
9.3.1. Monovalent Vaccines
9.3.2. Multivalent Vaccines
9.4. Market Attractiveness Analysis By Type
10. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) and Analysis By Route of Administration, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Route of Administration, 2022-2032
10.3.1. Intramuscular & Subcutaneous Administration
10.3.2. Oral Administration
10.3.3. Other Routes of Administration (Intranasal, Intradermal, and Percutaneous)
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Disease Indication, 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Disease Indication, 2022-2032
11.3.1. Influenza
11.3.2. Pneumococcal Diseases
11.3.3. Combination Vaccines
11.3.4. HPV
11.3.5. Herpes Zoster
11.3.6. Meningococcal Diseases
11.3.7. Rotavirus
11.3.8. MMR
11.3.9. Varicella
11.3.10. Hepatitis
11.3.11. DTP
11.3.12. Polio
11.3.13. COVID 19
11.3.14. Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)
11.4. Market Attractiveness Analysis By Disease Indication
12. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By End-user
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By End-user, 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By End-user, 2022-2032
12.3.1. Pediatric Vaccines
12.3.2. Adult Vaccines
12.4. Market Attractiveness Analysis By End-user
13. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Region
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Route of Administration
14.4.3. By Technology
14.4.4. By Type
14.4.5. By Disease Indication
14.4.6. By End-user
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Route of Administration
14.5.3. By Technology
14.5.4. By Type
14.5.5. By Disease Indication
14.5.6. By End-user
15. Latin America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Route of Administration
15.4.3. By Technology
15.4.4. By Type
15.4.5. By Disease Indication
15.4.6. By End-user
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Route of Administration
15.5.3. By Technology
15.5.4. By Type
15.5.5. By Disease Indication
15.5.6. By End-user
16. Europe Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Russia
16.4.1.6. Rest of Europe
16.4.2. By Route of Administration
16.4.3. By Technology
16.4.4. By Type
16.4.5. By Disease Indication
16.4.6. By End-user
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Route of Administration
16.5.3. By Technology
16.5.4. By Type
16.5.5. By Disease Indication
16.5.6. By End-user
17. Asia Pacific Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.1.4. Rest of Asia Pacific
17.4.2. By Route of Administration
17.4.3. By Technology
17.4.4. By Type
17.4.5. By Disease Indication
17.4.6. By End-user
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Route of Administration
17.5.3. By Technology
17.5.4. By Type
17.5.5. By Disease Indication
17.5.6. By End-user
18. Middle East and Africa Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Route of Administration
18.4.3. By Technology
18.4.4. By Type
18.4.5. By Disease Indication
18.4.6. By End-user
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Route of Administration
18.5.3. By Technology
18.5.4. By Type
18.5.5. By Disease Indication
18.5.6. By End-user
19. Key Countries Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. US Vaccines Market Analysis
19.2.1. Value Proportion Analysis by Market Taxonomy
19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.2.2.1. By Route of Administration
19.2.2.2. By Technology
19.2.2.3. By Type
19.2.2.4. By Disease Indication
19.2.2.5. By End-user
19.3. Canada Vaccines Market Analysis
19.3.1. Value Proportion Analysis by Market Taxonomy
19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.3.2.1. By Route of Administration
19.3.2.2. By Technology
19.3.2.3. By Type
19.3.2.4. By Disease Indication
19.3.2.5. By End-user
19.4. Mexico Vaccines Market Analysis
19.4.1. Value Proportion Analysis by Market Taxonomy
19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.4.2.1. By Route of Administration
19.4.2.2. By Technology
19.4.2.3. By Type
19.4.2.4. By Disease Indication
19.4.2.5. By End-user
19.5. Brazil Vaccines Market Analysis
19.5.1. Value Proportion Analysis by Market Taxonomy
19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.5.2.1. By Route of Administration
19.5.2.2. By Technology
19.5.2.3. By Type
19.5.2.4. By Disease Indication
19.5.2.5. By End-user
19.6. Germany Vaccines Market Analysis
19.6.1. Value Proportion Analysis by Market Taxonomy
19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.6.2.1. By Route of Administration
19.6.2.2. By Technology
19.6.2.3. By Type
19.6.2.4. By Disease Indication
19.6.2.5. By End-user
19.7. France Vaccines Market Analysis
19.7.1. Value Proportion Analysis by Market Taxonomy
19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.7.2.1. By Route of Administration
19.7.2.2. By Technology
19.7.2.3. By Type
19.7.2.4. By Disease Indication
19.7.2.5. By End-user
19.8. Italy Vaccines Market Analysis
19.8.1. Value Proportion Analysis by Market Taxonomy
19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.8.2.1. By Route of Administration
19.8.2.2. By Technology
19.8.2.3. By Type
19.8.2.4. By Disease Indication
19.8.2.5. By End-user
19.9. Russia Vaccines Market Analysis
19.9.1. Value Proportion Analysis by Market Taxonomy
19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.9.2.1. By Route of Administration
19.9.2.2. By Technology
19.9.2.3. By Type
19.9.2.4. By Disease Indication
19.9.2.5. By End-user
19.10. UK Vaccines Market Analysis
19.10.1. Value Proportion Analysis by Market Taxonomy
19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.10.2.1. By Route of Administration
19.10.2.2. By Technology
19.10.2.3. By Type
19.10.2.4. By Disease Indication
19.10.2.5. By End-user
19.11. China Vaccines Market Analysis
19.11.1. Value Proportion Analysis by Market Taxonomy
19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.11.2.1. By Route of Administration
19.11.2.2. By Technology
19.11.2.3. By Type
19.11.2.4. By Disease Indication
19.11.2.5. By End-user
19.12. Japan Vaccines Market Analysis
19.12.1. Value Proportion Analysis by Market Taxonomy
19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.12.2.1. By Route of Administration
19.12.2.2. By Technology
19.12.2.3. By Type
19.12.2.4. By Disease Indication
19.12.2.5. By End-user
19.13. South Korea Vaccines Market Analysis
19.13.1. Value Proportion Analysis by Market Taxonomy
19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.13.2.1. By Route of Administration
19.13.2.2. By Technology
19.13.2.3. By Type
19.13.2.4. By Disease Indication
19.13.2.5. By End-user
19.14. GCC Countries Vaccines Market Analysis
19.14.1. Value Proportion Analysis by Market Taxonomy
19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.14.2.1. By Route of Administration
19.14.2.2. By Technology
19.14.2.3. By Type
19.14.2.4. By Disease Indication
19.14.2.5. By End-user
19.15. South Africa Vaccines Market Analysis
19.15.1. Value Proportion Analysis by Market Taxonomy
19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.15.2.1. By Route of Administration
19.15.2.2. By Technology
19.15.2.3. By Type
19.15.2.4. By Disease Indication
19.15.2.5. By End-user
19.16. Turkey Vaccines Market Analysis
19.16.1. Value Proportion Analysis by Market Taxonomy
19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.16.2.1. By Route of Administration
19.16.2.2. By Technology
19.16.2.3. By Type
19.16.2.4. By Disease Indication
19.16.2.5. By End-user
19.16.3. Competition Landscape and Player Concentration in the Country
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. GlaxoSmithKline plc
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Strategy Overview
21.3.2. Merck & Co., Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Strategy Overview
21.3.3. Pfizer
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Strategy Overview
21.3.4. Sanofi SA
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Strategy Overview
21.3.5. CSL Limited
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Strategy Overview
21.3.6. Emergent BioSolutions Inc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Strategy Overview
21.3.7. Johnson & Johnson (J&J)
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Strategy Overview
21.3.8. AstraZeneca
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Strategy Overview
21.3.9. Bavarian Nordic A/S
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Strategy Overview
21.3.10. Mitsubishi Tanabe Pharma Corporation
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 2: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 3: Global Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 4: Global Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 5: Global Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 6: Global Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 7: Global Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 8: Global Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 9: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 10: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 11: Global Vaccines Market, By Region, 2015 – 2021
Table 12: Global Vaccines Market, By Region, 2022 – 2032
Table 13: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 14: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 15: North America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 16: North America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 17: North America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 18: North America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 19: North America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 20: North America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 21: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 22: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 23: North America Vaccines Market, By Country, 2015 – 2021
Table 24: North America Vaccines Market, By Country, 2022 – 2032
Table 25: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 26: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 27: Latin America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 28: Latin America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 29: Latin America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 30: Latin America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 31: Latin America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 32: Latin America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 33: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 34: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 35: Latin America Vaccines Market, By Country, 2015 – 2021
Table 36: Latin America Vaccines Market, By Country, 2022 – 2032
Table 37: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 38: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 39: Europe Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 40: Europe Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 41: Europe Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 42: Europe Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 43: Europe Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 44: Europe Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 45: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 46: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 47: Europe Vaccines Market, By Country, 2015 – 2021
Table 48: Europe Vaccines Market, By Country, 2022 – 2032
Table 49: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 50: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 51: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 52: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 53: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 54: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 55: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 56: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 57: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 58: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 59: Asia Pacific Vaccines Market, By Country, 2015 – 2021
Table 60: Asia Pacific Vaccines Market, By Country, 2022 – 2032
Table 61: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 62: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 63: MEA Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 64: MEA Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 65: MEA Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 66: MEA Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 67: MEA Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 68: MEA Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 69: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 70: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 71: MEA Vaccines Market, By Country, 2015 – 2021
Table 72: MEA Vaccines Market, By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 4: Global Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 5: Global Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 6: Global Vaccines Market Share, By Technology, 2022 & 2032
Figure 7: Global Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 8: Global Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 9: Global Vaccines Market Share, By End-user, 2022 & 2032
Figure 10: Global Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 11: Global Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 12: Global Vaccines Market Share, By Type, 2022 & 2032
Figure 13: Global Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 14: Global Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 15: Global Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 16: Global Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 17: Global Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 18: Global Vaccines Market Share, By Region, 2022 & 2032
Figure 19: Global Vaccines Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 20: Global Vaccines Market Attractiveness Index, By Region – 2022-2032
Figure 21: North America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 22: North America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 23: North America Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 24: North America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 25: North America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 26: North America Vaccines Market Share, By Technology, 2022 & 2032
Figure 27: North America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 28: North America Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 29: North America Vaccines Market Share, By End-user, 2022 & 2032
Figure 30: North America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 31: North America Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 32: North America Vaccines Market Share, By Type, 2022 & 2032
Figure 33: North America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 34: North America Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 35: North America Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 36: North America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 37: North America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 38: North America Vaccines Market Share, By Country, 2022 & 2032
Figure 39: North America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 40: North America Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 41: Latin America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 42: Latin America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 43: Latin America Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 44: Latin America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 45: Latin America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 46: Latin America Vaccines Market Share, By Technology, 2022 & 2032
Figure 47: Latin America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 48: Latin America Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 49: Latin America Vaccines Market Share, By End-user, 2022 & 2032
Figure 50: Latin America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 51: Latin America Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 52: Latin America Vaccines Market Share, By Type, 2022 & 2032
Figure 53: Latin America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 54: Latin America Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 55: Latin America Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 56: Latin America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 57: Latin America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 58: Latin America Vaccines Market Share, By Country, 2022 & 2032
Figure 59: Latin America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 60: Latin America Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 61: Europe Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 62: Europe Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 63: Europe Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 64: Europe Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 65: Europe Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 66: Europe Vaccines Market Share, By Technology, 2022 & 2032
Figure 67: Europe Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 68: Europe Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 69: Europe Vaccines Market Share, By End-user, 2022 & 2032
Figure 70: Europe Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 71: Europe Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 72: Europe Vaccines Market Share, By Type, 2022 & 2032
Figure 73: Europe Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 74: Europe Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 75: Europe Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 76: Europe Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 77: Europe Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 78: Europe Vaccines Market Share, By Country, 2022 & 2032
Figure 79: Europe Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 80: Europe Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 81: Asia Pacific Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 82: Asia Pacific Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 83: Asia Pacific Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 84: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 85: Asia Pacific Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 86: Asia Pacific Vaccines Market Share, By Technology, 2022 & 2032
Figure 87: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 88: Asia Pacific Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 89: Asia Pacific Vaccines Market Share, By End-user, 2022 & 2032
Figure 90: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 91: Asia Pacific Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 92: Asia Pacific Vaccines Market Share, By Type, 2022 & 2032
Figure 93: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 94: Asia Pacific Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 95: Asia Pacific Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 96: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 97: Asia Pacific Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 98: Asia Pacific Vaccines Market Share, By Country, 2022 & 2032
Figure 99: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 100: Asia Pacific Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 101: MEA Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 102: MEA Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 103: MEA Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 104: MEA Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 105: MEA Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 106: MEA Vaccines Market Share, By Technology, 2022 & 2032
Figure 107: MEA Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 108: MEA Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 109: MEA Vaccines Market Share, By End-user, 2022 & 2032
Figure 110: MEA Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 111: MEA Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 112: MEA Vaccines Market Share, By Type, 2022 & 2032
Figure 113: MEA Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 114: MEA Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 115: MEA Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 116: MEA Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 117: MEA Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 118: MEA Vaccines Market Share, By Country, 2022 & 2032
Figure 119: MEA Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 120: MEA Vaccines Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
